| Brand name |
Arzerra
|
|---|---|
| المخاطر |
Hepatitis B virus reactivation warning, Safety update on a fatal infusion reaction reported in a patient with Chronic lymphocytic leukemia (Cll) who was treated with intravenous ofatumumab, Risk of Progressive Multifocal Encephalopathy (PML) Following Ofatumumab Use. |
| Safety messages for healthcare practitioners |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Government websites use the protocol. HTTPS for encryption and security.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.